FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved a supplemental application for Plavix (clopidogrel) by Sanofi-Aventis U.S. LLC, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Ischemic Heart Disease
• Myocardial Infarction
• Peripheral Arterial Disease
• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Plavix (clopidogrel)

Snippet

SUPPL AP for PLAVIX (CLOPIDOGREL)